Valeant sweetens bid for Salix Pharma to $10.96bn to beat rival Endo International

Endo International, which was the only remaining bidder for Salix, has withdrawn from its attempt.



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/18VjqOQ March 17, 2015 at 11:18AM http://ift.tt/eA8V8J